GPB Capital Completes $30 Million Debt Investment in Emmaus Life Sciences

January 18, 2018

Responsive image

NEW YORK, Jan. 18, 2018 /PRNewswire/ — GPB Capital Holdings, LLC (GPB Capital) announced today that it has made a debt investment in Emmaus Life Sciences, Inc. (Emmaus). Proceeds from the investment will help Emmaus commercially launch Endari™ (L-glutmamine oral powder), its prescription…

Category: Precious Metals